Profit at Jamaica’s intra-island luxury bus service, Knutsford Express, rose 23 percent for the quarter ending November 2023 to $72 million up from $59, million in 2022 and 10 percent for the half year to $158 million from $143 million in 2022.

Knutsford Express
Revenues for the second quarter and the half year were up 19 percent respectively to $473 million from $398 million for the November 2022 quarter and for the half year, to $965 million from $830 million in 2022.
Profit resulted in 14 cents earnings per share for the quarter and 32 cents for the six months to November. ICInsider.com projects 85 cents for the year to May 2024.
The company generated net cash from operating activities of $225 million up from $173 million in 2022 but ended with cash outflows of $32 million that arose from payments of dividends, purchase of property and loan repayment, reduced the funds at the end of May of $87 million to $55 million at the end of November.
Much of the profit improvement arose from increased efficiency in the operations, following the introduction of new machinery.
The results emanated from a 27 percent jump in revenues to $315 million from $248 million for the same period the prior year. For the year to date revenues rose 8 percent to $869 million $803 million in 2022. Growth in revenues for the nine months to November was negatively affected by downtime of one of the CT units in Kingston in the previous quarter.
The group declared a dividend payable in January of 40 cents for a second consecutive quarter putting it at $1.60 annualised, for a 4.6 percent yield based on the current price. Traditionally the group was committed to paying 40 to 50 percent of profits, this seems to have temporarily changed with the fallout from the Covid-19 pandemic but could return in the near future.
Highlights of the good performance came from interest income, with the quarter jumping 22 percent to $11.6 billion from $9.5 billion in 2022 and by 31 percent for the full year to $40.8 billion with loans disbursed growing a robust 15 percent to $269 billion from $234.7 billion in 2022, after loan loss provisions. Non-accrual loans stood at $4.5 billion compared to $4 billion at the end of October 2022 and represent 1.6 percent of gross loans compared to October 2022 at 1.7 percent.
lower fair value losses on the investment portfolio, recognition of the insurance finance reserve on the adoption of IFRS 17 and profit generated for the year, partially offset by dividends paid. Total assets grew by $70 billion to $665 billion at October 2023.


For the first nine months of the year, revenues rose 9.7 percent to $117.8 billion, over the $107 billion earned for the nine months to September 2022. Profit before tax reached $8.8 billion, up 14 percent from $7.7 billion and net profit after tax attributable to shareholders of the group rose 14.2 percent to $6.4 billion from $5.6 billion.

The company indicated that revenues fell due to machine breakdown, although other areas saw growth in the modalities of X-ray and fluoroscopy cases.

Operations produced cash inflows of $356 million, up from $259 million in 2022 and at the end of the period with a surplus of $189 million that brought the total to $320.8 million up from just $99 million at the end of September. The 2023 growth in Cash inflows is after spending $72 million on acquiring property, plant and equipment, $50 million in dividend payments and $40 million used in repaying loans. Some of the amount on hand is earmarked to fund the acquisition of properties to be used for storage to allow for continued expansion of the business.